Needham Initiates Coverage On Carlsmed with Buy Rating, Announces Price Target of $17
Needham analyst David Saxon initiates coverage on Carlsmed (NASDAQ: CARL ) with a Buy rating and announces Price Target of $17.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.